| 注册
首页|期刊导航|中国药物经济学|瑞替普酶治疗急性心肌梗死患者的临床疗效

瑞替普酶治疗急性心肌梗死患者的临床疗效

周汝彬 刘建飞

中国药物经济学Issue(3):75-76,2.
中国药物经济学Issue(3):75-76,2.

瑞替普酶治疗急性心肌梗死患者的临床疗效

The Clinical Efficacy of Reteplase for Acute Myocardial Infarction

周汝彬 1刘建飞1

作者信息

  • 1. 湖北襄阳市中心医院北区,湖北襄阳 441021
  • 折叠

摘要

Abstract

Objective To investigate the clinical efficacy of reteplase for acute myocardial infarction.Methods In 66 patients with acute myocardial infarction were selected from January to 2014 the author place unit in 2013 February were as the research object,according to their hospitalization time sequence is divided into two groups,33 patients in the control group given urokinase therapy,33 patients with reteplase group was treated with reteplase therapy. Comparison of two groups of patients with clinical thrombolysis after recanalization rate,death rate and bleeding rate.Results Reteplase in patients with vascular recanalization rate was significantly higher than that of the control group(P<0.05);and the group of patients with bleeding rate,mortality rate were significantly lower than those of the control group(P<0.05).Conclusion Clinical therapeutic effect of the treatment of acute myocardial infarctionusing reteplase with high ideals,and higher safety.

关键词

心肌梗死/急性/瑞替普酶/尿激酶/疗效

Key words

Myocardial infarction/Acute/Reteplase/Urokinase/Curative effect

分类

医药卫生

引用本文复制引用

周汝彬,刘建飞..瑞替普酶治疗急性心肌梗死患者的临床疗效[J].中国药物经济学,2015,(3):75-76,2.

中国药物经济学

1673-5846

访问量0
|
下载量0
段落导航相关论文